Related Experiment Videos

[Quantitative behavior of eosinophil granulocytes in the bone marrow of children with acute lymphoblastic leukemia]

Folia Haematologica (Leipzig, Germany : 1928)
|January 1, 1978
PubMed

Insights

Eosinophil granulocytes in children with acute lymphoblastic leukemia (ALL) initially decrease with chemotherapy, then normalize during remission. Relapses cause further significant eosinophil reduction, indicating disease progression.

Area of Science:

  • Hematology
  • Pediatric Oncology

Background:

  • Acute lymphoblastic leukemia (ALL) is a common childhood cancer.
  • Eosinophils play a role in immune responses and can be affected by cancer therapies.

Purpose of the Study:

  • To investigate the quantitative behavior of eosinophil granulocytes in children with ALL during disease course and treatment.
  • To correlate eosinophil levels with treatment response, remission, and relapse.

Main Methods:

  • Quantitative analysis of eosinophil granulocytes in 31 children with ALL.
  • Monitoring eosinophil levels during chemotherapy (Memphis IV protocol), remission, and relapse phases.

Main Results:

  • Eosinophils initially decreased during chemotherapy, then increased to normal levels during remission.
  • Significant eosinophil decrease was observed during relapse and pre-final stages.
  • Bone marrow eosinophil counts showed greater diminution with each subsequent relapse, affecting maturation.

Conclusions:

  • Eosinophil granulocyte behavior is a potential indicator of ALL progression and treatment response.
  • The findings suggest a link between eosinophils, neutrophilic granulocytes, and the lymphocytic system in ALL.

Related Concept Videos